1st International COVID-19 Congress, México.

“This virus is here to stay. It is still killing, and it’s still changing. The risk remains of new variants emerging, causing new surges in cases and deaths”.

Dr Tedros Adhanom Ghebreyesus. Director-General of the WHO (World Health Organization).

Blvd. Kukulcán, retorno Gucumatz, Km 17, Lote 49, Segunda Etapa, Zona Hotelera, 77500, Cancún, Q. Roo

From 21 to 24

January 2025

About the event

The 1st International COVID-19 Congress, Mexico, consists of a 4-day in person event, includes conferences and discussion panels presented by national and international speakers, about diverse topics regarding this epidemic, that will analyze all known health effects to date, its evolution, and more. It is intended to all medical specialists, physicians, hospital directors, health first responders, nurses and health professionals in general.

More

About the event

We will provide an up-to-date, analytical, academic event, divided in two modalities: Conferences and Experts Discussion Panels, providing the opportunity to exchange points of view, experiences, etc.

Experts Panels

There will be more than 10 discussion panels provided by expert healthcare professionals, discussing themes like safety measures, preventive strategies, and diverse actions about COVID 19 pandemic.

Conferences

Conferences will be presented by specialists, with the main objective of gathering and taking advantage of all the up to date knowledge acquired by the experience throughout this pandemic.

Update. Training

Improving the quality of health care for our patients

Calendario

See you in:

Days
Hours
Minutes
Seconds
algunos de nuestros

Patrocinadores

Sponsors

flaticon
flaticon
flaticon
flaticon
flaticon
flaticon
flaticon
flaticon
algunos de nuestros

Event Schedule

algunos de nuestros

Speakers

The life-long learning encourages the critical thinking skills among health care professionals.

Dr. José Luis Pohls Arroyuelo

Maestría en administración y Especialidad en Salud Pública

Director General, Hospital Ángeles Pedregal

Dr. José Alfredo Merino Rajme

Cardiólogo Intervencionista

Ex Director del Centro Médico 20 de noviembre ISSSTE

Dr. Rafael Ricardo Valdez Vázquez

Director General de Centro Nacional de Programas Preventivos y Control de Enfermedades de la Secretaría de Salud

Dra. Leyla Soraya Camarillo Blancarte

Genetísta

Responsable Federal del Sistema de Vigilancia Epidemiológica de Bacterias Invasivas

¿Tickets for the congress?

Shortly, event tickets pre-sale will be opened
Tickets reservation for January 21, 22, 23 & 24, 2025

COVID-19 Blog

Keep informed on all news and updates of vaccines, virus variants and relevant information about COVID-19

FDA revises letter of authorization for the emergency use authorization for Paxlovid

EUA-labeled Paxlovid is no longer authorized for emergency use, regardless of the labeled or extended expiration date. For both

COVID-19 Vaccines for 2024-2025 (FDA)

Which updated COVID-19 vaccines are available? The FDA has approved and authorized for emergency use updated COVID-19 vaccines (2024-2025

COVID-19 Epidemiological update

Epidemiological update on COVID-19. Number of cases and deaths globally, regionally and nationally, with key data and trends. Epidemiological

Impact of COVID-19 on Healthy Life Expectancy of Older Adults in the Region of the Americas

Washington DC, 21 August 2024- The Region of the Americas has experienced a significant decline in the healthy life

FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines to Better Protect

August 22, 2024.- The U.S. Food and Drug Administration approved and granted emergency use authorization (EUA) for updated mRNA

FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect

August 30, 2024.- The U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of

Sales

For information about sponsorship opportunities, please call;

Telephone

+52 81 1527 5228

Email

rmarroquin@bmcm.mx
rmarroquin@congresocovid.com

Questions about the event

×